Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Hematopoietic and Lymphatic System Neoplasm 5Hematopoietic and Lymphoid System Neoplasm 4Malignant Solid Neoplasm 3Unspecified Adult Solid Tumor, Protocol Specific 2Advanced Malignant Solid Neoplasm 2Chemotherapy-Induced Peripheral Neuropathy 1

Interventions

Interviews as Topic 3Educational Status 3veliparib 2adavosertib 2Specimen Handling 2Palliative Care 2Methods 2Early Intervention, Educational 2trametinib 1spartalizumab 1siltuximab 1pembrolizumab 1pamiparib 1dinaciclib 1cabozantinib 1Temozolomide 1Pharmacogenomic Variants 1Patient Comfort 1Paclitaxel 1PT-100 dipeptide 1Nutrition Assessment 1Mindfulness-Based Stress Reduction 1Mindfulness 1Magnetic Resonance Spectroscopy 1Health Promotion 1Everolimus 1Diet Therapy 1Carboplatin 1Biopsy 1Behavior Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Advanced Malignant Solid Neoplasm × Methods × Other solid neoplasm × Clear all
NCT07141407 2026-05-29

Telephone-Based Coaching Sessions (TAC) to Improve Advance Care Planning Participation in Advanced Cancer Patients and Their Support Person

Fred Hutchinson Cancer Center

Phase NA Recruiting
80 enrolled
Other solid neoplasm

Advanced Malignant Solid Neoplasm

NCT06438588 2026-05-22

Fasting Mimicking Diet for Reducing Immune Related Adverse Events for Cancer Patients on Immune Checkpoint Inhibitors, FMD-ICI Trial

Mayo Clinic

Phase NA Recruiting
10 enrolled
Other solid neoplasm

Advanced Malignant Solid Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡